Patent: 10,682,395
✉ Email this page to a colleague
Summary for Patent: 10,682,395
| Title: | Dry growth hormone composition transiently linked to a polymer carrier |
| Abstract: | The present invention relates to dry compositions of rhGH polymer prodrug containing a lyoprotectant and, optionally, one or more than one excipient. Such compositions are stable for at least 1 year, when stored at 2-8° C. The invention further relates to methods of manufacturing said compositions, containers comprising such composition as well as a kit of parts. |
| Inventor(s): | Rasmussen Grethe Nørskov, Kindermann Susanne, Rau Harald, Wegge Thomas |
| Assignee: | Ascendis Pharma Endocrinology Division A/S |
| Application Number: | US15901350 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,682,395
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Ascendis Pharma Endocrinology Division A/s | SKYTROFA | lonapegsomatropin-tcgd | For Injection | 761177 | August 25, 2021 | ⤷ Start Trial | 2038-02-21 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,682,395
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201204334 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2011073234 | ⤷ Start Trial |
| United States of America | 9919033 | ⤷ Start Trial |
| United States of America | 9511122 | ⤷ Start Trial |
| United States of America | 2020261544 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
